Literature DB >> 17881645

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.

Ronald W Stam, Pauline Schneider, Paola de Lorenzo, Maria G Valsecchi, Monique L den Boer, Rob Pieters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17881645     DOI： 10.1182/blood-2007-05-091934

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

Review 1.  Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Emily B Heikamp; Ching-Hon Pui
Journal:  J Pediatr       Date:  2018-09-10       Impact factor: 4.406

2.  Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  Huining Kang; Carla S Wilson; Richard C Harvey; I-Ming Chen; Maurice H Murphy; Susan R Atlas; Edward J Bedrick; Meenakshi Devidas; Andrew J Carroll; Blaine W Robinson; Ronald W Stam; Maria G Valsecchi; Rob Pieters; Nyla A Heerema; Joanne M Hilden; Carolyn A Felix; Gregory H Reaman; Bruce Camitta; Naomi Winick; William L Carroll; ZoAnn E Dreyer; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

Review 3.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

4.  The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia.

Authors:  Henning Fedders; Ameera Alsadeq; Juliane Schmäh; Fotini Vogiatzi; Martin Zimmermann; Anja Möricke; Lennart Lenk; Udo Zur Stadt; Martin A Horstmann; Rob Pieters; Martin Schrappe; Martin Stanulla; Gunnar Cario; Denis M Schewe
Journal:  Haematologica       Date:  2017-08-24       Impact factor: 9.941

Review 5.  Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.

Authors:  Alisa B Lee-Sherick; Rachel M A Linger; Lia Gore; Amy K Keating; Douglas K Graham
Journal:  Br J Haematol       Date:  2010-08-31       Impact factor: 6.998

Review 6.  Infant acute lymphoblastic leukemia: Lessons learned and future directions.

Authors:  Rob Pieters
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

Review 7.  Treatment of infant leukemias: challenge and promise.

Authors:  Patrick Brown
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

8.  Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.

Authors:  P De Lorenzo; A V Moorman; R Pieters; Z E Dreyer; N A Heerema; A J Carroll; S P Hunger; R Harvey; C L Willman; M Devidas; M-G Valsecchi; C J Harrison
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

Review 9.  The molecular biology of mixed lineage leukemia.

Authors:  Robert K Slany
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

10.  Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.

Authors:  Emma M C Driessen; Eddy H J van Roon; Jill A P Spijkers-Hagelstein; Pauline Schneider; Paola de Lorenzo; Maria Grazia Valsecchi; Rob Pieters; Ronald W Stam
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.